While leukocytes, CRP, IL-6, and PCT are widely recognized as important markers of inflammation and infection, it is acknowledged that other cytokines and biomarkers may provide valuable insights into the effectiveness of hemoadsorption therapy. The gene discussed is IL6; the disease is infection.